bioAffinity
  • Home
  • Publications
  • News
  • About Us
  • Videos
  • Contact
  • Investor Relations
  • Careers
Select Page

Sputum analysis by flow cytometry; an effective platform to analyze the lung environment

by Maria Zannes | Aug 17, 2022 | Publications

“Sputum analysis by flow cytometry; an effective platform to analyze the lung environment” PLoS ONE – August 17, 2022   Authors Bederka L.H., Sanchez JR, Rebeles J, Araujo PR, Grayson MH, Lai S-C, et al.   Abstract Low-dose computed tomography...

Quality-Controlled Sputum Analysis by Flow Cytometry

by Maria Zannes | Aug 9, 2021 | Publications

Journal of Visualized Experiments (JoVE) – August 9, 2021 AuthorsMarcia Grayson, Shao-Chiang Lai, Lydia H. Bederka, Patricia Araujo, Jamila Sanchez, Xavier T. Reveles, Vivienne I. Rebel, Jennifer Rebeles AbstractSputum, widely used to study the cellular content and...

Meso-tetra (4-carboMeso-tetra (4-carboxyphenyl) Porphyrin (TCPP) is taken up in Cancer Cells by the CD320 Receptor

by Maria Zannes | Jul 2, 2021 | Publications

“Meso-tetra (4-carboMeso-tetra (4-carboxyphenyl) porphyrin (TCPP) is taken up in cancer cells by the CD320 receptor” International Conference on Porphyrins and Phthalocyanines (ICPP) ICPP-11, June 26 through July 2, 2021   Authors David J. Elzi, William E. Bauta,...

Selective Cancer Cell Killing by Dual siRNA Knockdown of CD320 and LRP2 Receptors

by Maria Zannes | Jun 25, 2021 | Publications

“Selective Cancer Cell Killing by Dual siRNA Knockdown of CD320 and LRP2 Receptors” RNA Therapeutics Institute’s 2021 RNA Therapeutics Symposium at the University of Massachusetts Medical School June 23 – 25, 2021   Authors David J. Elzi, William E. Bauta,...

Simultaneous knockdown of CD320 and LRP2 receptors is selectively toxic to cancer cells but not normal cells

by Maria Zannes | May 22, 2021 | Publications

“Simultaneous knockdown of CD320 and LRP2 receptors is selectively toxic to cancer cells but not normal cells” At the American Association of Cancer Research (AACR) Annual Meeting 2021, April-May, 2021   Authors David J. Elzi, William Bauta,...

Identification of a novel mechanism for meso‐tetra (4‐carboxyphenyl) porphyrin (TCPP) uptake in cancer cells

by Maria Zannes | Feb 25, 2021 | Publications

“Identification of a novel mechanism for meso‐tetra (4‐carboxyphenyl) porphyrin (TCPP) uptake in cancer cells” Journal of the Federation of Societies for the Study of Experimental Biology (FASEB Journal), Feb. 25, 2021   Authors David J. Elzi, William E....
« Older Entries
Next Entries »

Categories

  • Articles (28)
  • Events (38)
  • News (53)
  • Press Releases (157)
  • Publications (19)

Recent Posts

  • bioAffinity Technologies Presents Positive Research Findings for its Novel Diagnostic Platform Technology to Identify Optimal Therapies for Asthma Patients March 3, 2026
  • “Sputum as a Diagnostic Tool for the Treatment of Asthma” American Academy of Allergy, Asthma and Immunology (AAAAI) 2026 Annual Meeting March 1, 2026 Authors R. Titone, D.A. Porraz, D.W. Putnam, R.P. Jacob, W.E. Bauta and D.J. Elzi March 1, 2026
  • bioAffinity Technologies Announces Validation Study with Brooke Army Medical Center to Expand Sample Collection Options for the CyPath® Lung Noninvasive Early Detection Lung Cancer Test February 25, 2026
  • New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer February 19, 2026
  • Clinical Utility of bioAffinity Technologies’ CyPath® Lung Test Demonstrated in Real-World Case Study February 17, 2026
CyPath Lung Test

Main Menu

  • Home
  • Publications
  • News
  • About Us
  • Videos
  • Contact
  • Investor Relations
  • Careers
Copyright © 2023 bioAffinity Technologies, Inc.